Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
AssigneeDyax Corp.
InventorsArumugam Muruganandam, Christopher Tenhoor, Laetitia Devy
Life of this patent
Estimating the term…
Abstract
Provided are anti-idiotypic antibodies specific for a CDR of an anti-MMP-14 antibody for use as reagents in novel assays for anti-MMP-14 antibodies, pharmaceutical compositions and vaccines.
Claims16
An isolated protein comprising a heavy chain (HC) immunoglobulin variable domain sequence and a light chain (LC) immunoglobulin variable domain sequence, wherein the HC and LC immunoglobulin variable domain sequences form an antigen binding site that binds to an anti-MMP-14 antibody;
- and the protein comprises one or more of the following characteristics:
- (a) a human CDR or human framework region;
- (b) the HC immunoglobulin variable domain sequence comprises one or more CDRs that are at least 85% identical to a CDR of a HC variable domain of 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04;
- (c) the LC immunoglobulin variable domain sequence comprises one or more CDRs that are at least 85% identical to a CDR of a LC variable domain of 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04;
- (d) the LC immunoglobulin variable domain sequence is at least 85% identical to a LC variable domain of 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04;
- (e) the HC immunoglobulin variable domain sequence is at least 85% identical to a HC variable domain of 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04;
- and
- (f) the protein binds an epitope that overlaps with an epitope bound by 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04.
An isolated nucleic acid comprising a sequence that encodes a polypeptide that comprises a sequence at least 80% identical to the sequence of a variable domain of 539C-M0016-E11;
- 539C-M0021-E01;
- 539C-R0010-A01;
- 539C-R0010-B01;
- 539C-R0010-B06;
- 539C-R0010-C05;
- 539C-R0010-C06;
- 539C-R0010-D06;
- 539C-R0010-E06;
- 539C-R0010-F05;
- 539C-R0010-F06;
- or 539C-R0004-G04.
Dependencies are inferred from the claim text.